Nutrien Ltd. (NYSE:NTR) Shares Purchased by TD Private Client Wealth LLC

TD Private Client Wealth LLC boosted its holdings in Nutrien Ltd. (NYSE:NTRFree Report) by 4.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 43,610 shares of the company’s stock after buying an additional 1,717 shares during the period. TD Private Client Wealth LLC’s holdings in Nutrien were worth $2,098,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in NTR. Cetera Advisors LLC boosted its stake in Nutrien by 21.3% in the 1st quarter. Cetera Advisors LLC now owns 5,897 shares of the company’s stock worth $321,000 after buying an additional 1,036 shares during the last quarter. CWM LLC boosted its stake in Nutrien by 6.1% in the 2nd quarter. CWM LLC now owns 5,923 shares of the company’s stock worth $302,000 after buying an additional 338 shares during the last quarter. Sequoia Financial Advisors LLC acquired a new stake in Nutrien in the 2nd quarter worth about $256,000. Royal Fund Management LLC acquired a new stake in Nutrien in the 2nd quarter worth about $829,000. Finally, Blue Trust Inc. lifted its stake in shares of Nutrien by 12.4% in the 2nd quarter. Blue Trust Inc. now owns 4,075 shares of the company’s stock valued at $221,000 after purchasing an additional 450 shares in the last quarter. 63.10% of the stock is owned by institutional investors and hedge funds.

Nutrien Price Performance

NTR stock opened at $47.93 on Friday. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. Nutrien Ltd. has a 52-week low of $44.65 and a 52-week high of $60.87. The stock’s 50 day moving average is $47.92 and its two-hundred day moving average is $49.17. The company has a market capitalization of $23.60 billion, a PE ratio of 32.17, a P/E/G ratio of 1.72 and a beta of 0.80.

Nutrien (NYSE:NTRGet Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.43 by ($0.04). Nutrien had a return on equity of 6.99% and a net margin of 2.79%. The business had revenue of $5.35 billion for the quarter, compared to analysts’ expectations of $5.26 billion. During the same quarter in the prior year, the firm earned $0.35 earnings per share. Nutrien’s revenue for the quarter was down 5.0% compared to the same quarter last year. Analysts predict that Nutrien Ltd. will post 3.49 earnings per share for the current fiscal year.

Nutrien Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 17th. Shareholders of record on Tuesday, December 31st will be issued a dividend of $0.939 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This is an increase from Nutrien’s previous quarterly dividend of $0.54. This represents a $3.76 annualized dividend and a yield of 7.84%. Nutrien’s payout ratio is currently 144.97%.

Analyst Ratings Changes

Several equities analysts have recently weighed in on NTR shares. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $60.00 price objective on shares of Nutrien in a research note on Friday, September 20th. CIBC reaffirmed an “outperformer” rating and issued a $55.00 price objective (down from $60.00) on shares of Nutrien in a research note on Tuesday. Barclays reduced their price objective on Nutrien from $68.00 to $55.00 and set an “overweight” rating on the stock in a research note on Friday, August 16th. UBS Group lowered Nutrien from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $66.00 to $51.00 in a research note on Thursday, October 10th. Finally, Oppenheimer started coverage on Nutrien in a research note on Thursday. They issued an “outperform” rating and a $60.00 price objective on the stock. Three research analysts have rated the stock with a sell rating, four have issued a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat, Nutrien has a consensus rating of “Hold” and a consensus target price of $58.95.

View Our Latest Research Report on Nutrien

Nutrien Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Featured Articles

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.